These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4366348)

  • 61. [Radioimmunoassay of angiotensin].
    Fukuchi S
    Saishin Igaku; 1971 Jun; 26(6):1110-5. PubMed ID: 4329055
    [No Abstract]   [Full Text] [Related]  

  • 62. [Illustration of an original radioimmunological method for the determination of a renin inhibitor in human plasma].
    Baggio B; Favaro S; Antonello A; Todesco S; Borsatti A; Campanacci L
    Quad Sclavo Diagn; 1972 Mar; 8(1):164-70. PubMed ID: 4351702
    [No Abstract]   [Full Text] [Related]  

  • 63. [Direct radioimmunochemical determination of plasmatic renin activity].
    Vincent M; Geyssant A; Sassard J
    C R Seances Soc Biol Fil; 1972; 166(4):643-8. PubMed ID: 4346795
    [No Abstract]   [Full Text] [Related]  

  • 64. Relationship between plasma phosphate concentration and hematocrit in uremic patients undergoing hemodialysis.
    Gonella M
    Nephron; 1980; 26(2):100. PubMed ID: 7412960
    [No Abstract]   [Full Text] [Related]  

  • 65. Suppression of renin in diabetic patients under chronic dialysis treatment.
    Kaneda H; Matsumoto J; Haruyama T; Yoshikawa K; Takeuchi M; Murata T
    Tohoku J Exp Med; 1979 Feb; 127(2):169-75. PubMed ID: 760263
    [No Abstract]   [Full Text] [Related]  

  • 66. Intensive Hemodialysis Fails to Reduce Plasma Levels of Uremic Solutes.
    Sirich TL; Meyer TW
    Clin J Am Soc Nephrol; 2018 Mar; 13(3):361-362. PubMed ID: 29444901
    [No Abstract]   [Full Text] [Related]  

  • 67. [Significance of peptides in the molecular etiology of uremic toxemia].
    Menyhárt J; Gróf J
    Orv Hetil; 1979 Jul; 120(30):1795-801. PubMed ID: 471491
    [No Abstract]   [Full Text] [Related]  

  • 68. On platelet fibrinogen in plasma defibrinogenated dogs and in uremic patients before and after hemodialysis.
    Johnsson H
    Thromb Res; 1975 Jul; 7(1):161-74. PubMed ID: 1154334
    [No Abstract]   [Full Text] [Related]  

  • 69. Determining plasma-renin activity.
    Vallotton MB
    Lancet; 1969 Apr; 1(7599):840. PubMed ID: 4180393
    [No Abstract]   [Full Text] [Related]  

  • 70. Letter: Assay of plasma-renin activity.
    Geoghegan J; Heffernan A
    Lancet; 1973 Dec; 2(7843):1451-2. PubMed ID: 4128770
    [No Abstract]   [Full Text] [Related]  

  • 71. Determination of arterial blood ammonia in uremic patients before and after hemodialysis using three different ammonia methods.
    Huizenga JR; Mulder B; Stegeman CA; Ament W; Teelken AW
    Artif Organs; 2002 Sep; 26(9):815-6; author reply 816. PubMed ID: 12197941
    [No Abstract]   [Full Text] [Related]  

  • 72. Elevated bile acid serum concentrations in uremics.
    Balestri PL; Cupisti A
    Nephron; 1996; 72(2):325. PubMed ID: 8684552
    [No Abstract]   [Full Text] [Related]  

  • 73. The influence of hemodiafiltration on blood pressure regulation.
    Levy SB; Stone RA; Ford CA; Beans E; Henderson LW
    Trans Am Soc Artif Intern Organs; 1977; 23():691-3. PubMed ID: 910401
    [No Abstract]   [Full Text] [Related]  

  • 74. Computer methods, uremic encephalopathy, and adequacy of dialysis.
    Bourne JR; Teschan PE
    Kidney Int; 1983 Oct; 24(4):496-506. PubMed ID: 6358638
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Applications of computer technology to the monitoring of patients treated by periodic hemodialysis].
    Degoulet P; Marichal JF; Cournoyer G; Meloche H; Lapierre L; Piette Y
    Union Med Can; 1976 Aug; 105(8):1217-22. PubMed ID: 982708
    [No Abstract]   [Full Text] [Related]  

  • 76. [Introduction to computers. 10. Control system at the hemodialysis center (2)].
    Wada T; Kondo K; Sato S
    Kangogaku Zasshi; 1981 Oct; 45(10):1169-72. PubMed ID: 6798269
    [No Abstract]   [Full Text] [Related]  

  • 77. [Introduction to computer science. 9. Control system at the hemodialysis center].
    Wada T; Kondo K; Sato S
    Kangogaku Zasshi; 1981 Sep; 45(9):1049-52. PubMed ID: 6798282
    [No Abstract]   [Full Text] [Related]  

  • 78. [Behavior of intradialysis curves of the PRA (Plasma Renin Activity) in a group of uremic patients during a periodic hemodialysis treatment].
    Farinelli A; Bagni B; Squerzanti R; Candini GC; Gilli P
    Minerva Nefrol; 1973; 20(6):376-89. PubMed ID: 4366348
    [No Abstract]   [Full Text] [Related]  

  • 79. [Use of saralasin in hypertensive uremic patients under periodic hemodialysis treatment].
    Cappelli G; Vagge R; Lamperi S
    Minerva Nefrol; 1979; 26(1):5-8. PubMed ID: 471322
    [No Abstract]   [Full Text] [Related]  

  • 80. [Dopamine 17-beta-hydroxylase in chronic uremic patients under periodic hemodialytic treatment].
    Cagossi M; Pigliucci GM; Ruvolo MR; Porcelli G
    Chir Patol Sper; 1979 Dec; 27(6):579-89. PubMed ID: 400642
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.